source
- Experts urge FDA to require credentials for psychedelic therapy providersAt a recent public hearing, mental health experts called on the FDA to adopt safety measures as it pushes to speed up psychedelic therapy development. The experts specifically recommended that pro…
- FDA issues warning letters to Bausch & Lomb and Indian API maker over GMP lapsesThe U.S. Food and Drug Administration sent warning letters to two companies after finding violations of good manufacturing practice. Bausch & Lomb, which produces ophthalmic products, was cited f…